Analysts See $0.57 EPS for HDFC Bank Limited (HDB); Laboratory of America Holdings Common (LH) Shorts Decreased By 12.88%

HDFC Bank Limited (NYSE:HDB) Logo

Analysts expect HDFC Bank Limited (NYSE:HDB) to report $0.57 EPS on January, 17.HDB’s profit would be $911.13M giving it 27.39 P/E if the $0.57 EPS is correct. After having $0.49 EPS previously, HDFC Bank Limited’s analysts see 16.33% EPS growth. The stock decreased 0.56% or $0.35 during the last trading session, reaching $62.46. About 948,769 shares traded. HDFC Bank Limited (NYSE:HDB) has risen 22.74% since January 16, 2019 and is uptrending. It has outperformed by 22.74% the S&P500. Some Historical HDB News: 15/03/2018 – HDFC BANK COMPLETED ISSUE OF INR23B 2025 BONDS AT 8.10%; 30/04/2018 – HDFC TO PAY INR16.5/SHR AS FINAL DIVIDEND; 03/04/2018 – HDFC EXPECTS TO REPORT INR3B PROFIT ON INVESTMENT SALE IN 4Q; 24/04/2018 – HDFC TO CONSIDER ISSUE OF REDEEMABLE NCDS, HYBRID INSTRUMENTS; 15/03/2018 – HDFC ASSET MANAGEMENT COMPANY LIMITED FILES FOR IPO; 03/04/2018 – HDFC: AS AT DEC 31, AMOUNT IN PROVISIONS/CONTINGENCIES INR48.9B; 21/04/2018 – INDIA’S HDFC BANK LTD HDBK.NS – MARCH QUARTER GROSS NPA 1.3 PERCENT VERSUS 1.29 PERCENT PREVIOUS QUARTER; 03/04/2018 – HDFC: PROFIT FROM SALE INVESTMENTS IN MARCH QTR WAS INR3B; 03/04/2018 – HDFC SAYS ADDITIONAL PROVISION BEING DONE VOLUNTARILY; 22/04/2018 – BSE Mumbai Bourse: Results from HDFC Bank for Apr 01 to Mar 31

Laboratory Corporation of America Holdings Common (NYSE:LH) had a decrease of 12.88% in short interest. LH’s SI was 1.68 million shares in January as released by FINRA. Its down 12.88% from 1.93 million shares previously. With 790,000 avg volume, 2 days are for Laboratory Corporation of America Holdings Common (NYSE:LH)’s short sellers to cover LH’s short positions. The SI to Laboratory Corporation of America Holdings Common’s float is 1.68%. The stock decreased 1.20% or $2.16 during the last trading session, reaching $178.23. About 758,241 shares traded or 29.07% up from the average. Laboratory Corporation of America Holdings (NYSE:LH) has risen 19.56% since January 16, 2019 and is uptrending. It has outperformed by 19.56% the S&P500. Some Historical LH News: 25/04/2018 – Laboratory Corporation 1Q EPS $1.67; 26/04/2018 – Airware Labs Announces Name Change to ltem 9 Labs Corp. and New Ticker Symbol “INLB”; 24/04/2018 – LABCORP – CO, MOUNT SINAI HEALTH SYSTEM HAVE BEGUN IMPLEMENTING PROGRAM TO STANDARDIZE & OPTIMIZE INPATIENT LAB SERVICES ACROSS MOUNT SINAI SYSTEM; 01/05/2018 – Moody’s: Labcorp’s Divestiture Of Food Solutions Business Is Credit Positive; 21/04/2018 – DJ Nano Labs Corp, Inst Holders, 1Q 2018 (CTLE); 06/03/2018 – LABCORP – ON TRACK TO DELIVER $150 MLN IN CUMULATIVE NEW REVENUE FROM COVANCE ACQUISITION THROUGH 2018 – SEC FILING; 25/04/2018 – Labcorp Closes Above 50-Day Moving Average: Technicals; 03/04/2018 – Triad Bus Jour: LabCorp cuts deal for 200K+ square feet in RTP; 25/04/2018 – LabCorp quarterly profit falls 5.4 pct; 25/05/2018 – LabCorp: Will Be A Preferred National Laboratory for Substantially All of Aetna’s Members Beginning 2019

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $17.31 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 23.48 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

Investors sentiment increased to 1.04 in 2019 Q3. Its up 0.11, from 0.93 in 2019Q2. It is positive, as 31 investors sold Laboratory Corporation of America Holdings shares while 211 reduced holdings. 63 funds opened positions while 188 raised stakes. 85.85 million shares or 0.12% less from 85.95 million shares in 2019Q2 were reported. Mirae Asset Investments reported 5,325 shares. Guardian Life Co Of America accumulated 287 shares or 0.01% of the stock. Brinker Capital invested in 18,069 shares or 0.1% of the stock. Virginia-based Burney has invested 0.21% in Laboratory Corporation of America Holdings (NYSE:LH). Capital Mgmt Lc holds 21,608 shares or 0.2% of its portfolio. United Asset Strategies stated it has 20,145 shares. Invesco holds 0.05% or 1.09M shares. Cullen Frost Bankers invested in 0.04% or 8,513 shares. State Board Of Administration Of Florida Retirement invested in 142,153 shares. Asset Mngmt One invested 0.04% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Citigroup Inc holds 101,722 shares or 0.01% of its portfolio. Paloma Ptnrs Management Com, a Connecticut-based fund reported 4,778 shares. Paradigm Asset Company Limited Liability Corporation owns 700 shares. Canada Pension Plan Investment Board holds 0.05% or 141,982 shares in its portfolio. Stephens Incorporated Ar invested in 0.01% or 1,766 shares.

Among 6 analysts covering Laboratory Corporation of America Holdings Common Stock (NYSE:LH), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Laboratory Corporation of America Holdings Common Stock has $21000 highest and $170 lowest target. $193’s average target is 8.29% above currents $178.23 stock price. Laboratory Corporation of America Holdings Common Stock had 10 analyst reports since July 26, 2019 according to SRatingsIntel. The firm has “Overweight” rating given on Thursday, August 8 by KeyBanc Capital Markets. The stock of Laboratory Corporation of America Holdings (NYSE:LH) earned “Hold” rating by Canaccord Genuity on Thursday, October 24. The rating was maintained by Robert W. Baird with “Buy” on Thursday, October 24. UBS maintained it with “Buy” rating and $20000 target in Monday, October 21 report. The stock of Laboratory Corporation of America Holdings (NYSE:LH) has “Overweight” rating given on Friday, July 26 by Morgan Stanley. Morgan Stanley maintained it with “Overweight” rating and $20100 target in Friday, August 23 report.

More notable recent Laboratory Corporation of America Holdings (NYSE:LH) news were published by: Finance.Yahoo.com which released: “Do You Like Laboratory Corporation of America Holdings (NYSE:LH) At This P/E Ratio? – Yahoo Finance” on January 06, 2020, also Finance.Yahoo.com with their article: “LabCorp to Announce Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020 – Yahoo Finance” published on January 13, 2020, Finance.Yahoo.com published: “LabCorp and Covance Launch Extensive Preclinical, Clinical and Post-Approval Cell and Gene Therapy Development Solutions – Yahoo Finance” on January 13, 2020. More interesting news about Laboratory Corporation of America Holdings (NYSE:LH) were released by: Finance.Yahoo.com and their article: “LabCorp and Covance Connect Sponsors with Patients Virtually with an Expanded Suite of Decentralized Trial Solutions – Yahoo Finance” published on December 18, 2019 as well as Finance.Yahoo.com‘s news article titled: “LabCorp is Scheduled to Present at the 38th Annual J.P. Morgan Healthcare Conference – Yahoo Finance” with publication date: January 06, 2020.

HDFC Bank Limited provides a range of banking and financial services to individuals and businesses in India, Bahrain, Hong Kong, and Dubai. The company has market cap of $99.84 billion. The firm operates in Treasury, Retail Banking, Wholesale Banking, and Other Banking Business divisions. It has a 120.7 P/E ratio. It accepts savings accounts, salary accounts, current accounts, fixed and recurring deposits, demat accounts, safe deposit lockers, and rural accounts, as well as offshore accounts and deposits.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart